Shamin Kinathil, MSc

PhD (candidate), Australian National University
The Kirby Institute for infection and immunity in society, The University of New South Wales
Sydney Australia

Papers:

COS2-5 COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE TRIPLE THERAPY WITH PROTEASE INHIBITORS IN TREATMENT-NAïVE PERSONS WITH HEPATITIS C USING A STOCHASTIC AGENT-BASED MODEL